从连续性进行统计， 有2只股获南向资金连续3天以上净买入，连续净买入天数较多的有建设银行、美 团-W，连续净买入天数分别为7天、4天。以其间净买入金额统计，净买入金额最多的是建设银行，合 计净买入为55.09亿港元，其次是美团-W合计净买入为24.40亿港元。有2只股获连续净卖出，净卖出金 额居前的有腾讯控股、小米集团-W等，合计净卖出金额分别为152.32亿港元、17.32亿港元。（数据 宝） | 代码 | 简称 | 成交金额（万港元） | 成交净买入（万港元） | 今日涨跌幅（%） | | --- | --- | --- | --- | --- | | 00939 | 建设银行 | 191005.37 | 68932.56 | 0.58 | | 03690 | 美团-W | 234601.69 | 65596.17 | 0.66 | | 00883 | 中国海洋石油 | 197099.26 | 58698.23 | 1.48 | | 01093 | 石药集团 | 74160.80 | 36372.53 | 3.49 | | 01530 | 三生制药 | 228598.21 | 26829.29 | 8.7 ...

Group 1 - Southbound funds recorded a net purchase of 1.427 billion yuan today [1] - In the Hong Kong Stock Connect (Shanghai), China Construction Bank and CNOOC received net purchases of 689 million HKD and 616 million HKD respectively [1] - Alibaba-W had the highest net sell amount at 543 million HKD [1] Group 2 - In the Hong Kong Stock Connect (Shenzhen), CSPC Pharmaceutical and Pop Mart received net purchases of 364 million HKD and 139 million HKD respectively [1] - Tencent Holdings had the highest net sell amount at 792 million HKD [1]

Group 1 - The Hang Seng Index rose by 1.29%, gaining 301 points to close at 23,634 points, while the Hang Seng Technology Index increased by 1.32% and the Hang Seng Biotechnology Index surged by 4.26% [1] - Ningde Times (03750) saw a significant increase of over 16% on its first day of trading on the Hong Kong Stock Exchange [1] - 3SBio (01530) experienced a dramatic rise of 35%, nearing its historical high, following an authorization agreement with Pfizer for a PD-1/VEGF dual antibody, with Pfizer making an upfront payment of $1.25 billion and potential milestone payments up to $4.8 billion [1] Group 2 - Yiming Anke-B (01541) rose over 10% after receiving a $5 million payment from Axion Bio, indicating a promising outlook in the self-immune field for IMM0306 [2] - Basilea Pharmaceuticals-B (02616) increased by over 18% after presenting five new research results at the 2025 AACR conference [2] - Rongchang Bio (09995) rose over 14% due to the addition of new indications for Vidi Xi monoclonal antibody, with Q1 performance slightly exceeding expectations [2] Group 3 - Xiaomi Group-W (01810) increased by nearly 4% ahead of the release of multiple new products, with its self-developed SoC "Xuanjie" expected to launch soon [5] - Alibaba Pictures (01060) surged over 17%, reporting an adjusted EBITDA profit of 809 million yuan for the year, a 61% year-on-year increase [6] - Alibaba Health (00241) fell over 4% post-earnings despite a more than 62% year-on-year increase in net profit, as it did not declare a final dividend [6]

Market Overview - The Hang Seng Index rose 2.1% last week, closing at 23,345 points, marking the fifth consecutive week of gains[1] - The Hang Seng Tech Index increased by 2.0%, closing at 5,281 points[1] - Average daily trading volume increased by 16.1% week-on-week to over HKD 232.5 billion[1] - Net outflow from the Hong Kong Stock Connect was approximately HKD 8.7 billion for the week, with a significant reduction in cumulative net inflow to HKD 16.8 billion over the past 20 days[1] Sector Performance - The financial sector surged by 3.8%, driven mainly by domestic banks and insurers[1] - Industrial, energy, and telecommunications sectors also saw gains of 2% or more over the week[1] Investment Sentiment - Since mid-April, the flow of funds through the Hong Kong Stock Connect has been volatile, with a record net outflow of HKD 18.5 billion on May 12, indicating a cautious stance from southbound investors[2] - The current AH premium index has dropped to the 16.0 percentile since 2020, suggesting insufficient value for aggressive buying[2] - The Hang Seng Index faces significant resistance in the 23,500-24,000 point range, with potential for continued volatility if southbound fund support diminishes[2] Macro Dynamics - Moody's downgraded the U.S. long-term sovereign credit rating from Aaa to Aa1, citing structural debt imbalance and increasing fiscal deficit pressures[3] - The U.S. federal debt-to-GDP ratio is projected to rise from 98% in 2024 to 134% by 2035, raising concerns about long-term repayment capacity[3] - Despite the downgrade, Moody's maintains that systemic risk has not reached a critical point, and market reactions will depend more on policy responses and economic data than on the rating change itself[3] Industry Developments - The Hang Seng Healthcare Index rose by 0.6%, with notable gains from companies like CSPC Pharmaceutical (3.1% to 3.9% increase)[4] - CSPC signed an exclusive licensing agreement for a cancer treatment in the U.S., receiving an upfront payment of USD 15 million and potential milestone payments of up to USD 25 million[4] - The IPO of Heng Rui Medicine received a "subscribe" rating, with projected revenue growth of 7.3% and net profit growth of 10.1% for 2023-24[4][7] New Drug Approvals - Rongchang Biotech's new indication for its drug has been approved, expected to boost sales significantly[11] - The company reported a 59.1% year-on-year increase in revenue to RMB 530 million for Q1 2025, with a reduction in net loss by 27.2%[13] - Target price for Rongchang Biotech has been raised to HKD 45.00, reflecting positive adjustments in revenue and profit forecasts[14]

Group 1 - CICC expects companies like Mixue Group (02097) and Bruker (00325) to be included in the Hong Kong Stock Connect list following the recent adjustments to the Hang Seng Index [1] - Horizon Robotics, listed in October last year, has met the requirements for inclusion in the Hong Kong Stock Connect after being added to the Hang Seng Index in February [1] - CICC estimates that passive fund inflows for companies like ZTO Express and NetEase will be significant, with expected inflows of $128 million and $218 million respectively [1] Group 2 - The Nasdaq Golden Dragon China Index fell by 0.17%, while major US indices showed slight gains, with the Dow Jones up 0.32% [2] - Notable gains were seen in the pharmaceutical and precious metals sectors, with Novavax rising over 15% [2] - The Hang Seng Index ADR increased by 0.52%, indicating a positive sentiment in the Hong Kong market [2] Group 3 - The World Health Organization's Director-General emphasized the need for global cooperation to address unprecedented public health challenges during the 78th World Health Assembly [3] - The WHO faces a budget shortfall of $1.7 billion over the next two years, which poses a significant challenge to its global health mission [3] Group 4 - Huawei's HarmonyOS-powered personal computers were officially launched, marking a significant breakthrough for domestic operating systems in the PC sector [4] - The HarmonyOS computers support over 1,100 external device connections and have adapted over 1,000 applications [4] Group 5 - Shandong Xinhua Pharmaceutical received approval for the listing of Eicosapentaenoic Acid Ethyl Ester, marking a significant milestone in its product development [5] - The approval was granted by the National Medical Products Administration after the company submitted its application in June 2023 [5] Group 6 - Huaxing Capital announced the successful listing of its portfolio company, Weigao Blood Purification Products, on the Shanghai Stock Exchange [6] - Tian Cai Holdings is negotiating to provide instant delivery systems for major online supermarkets, enhancing its service offerings [6] Group 7 - BYD established its European headquarters in Hungary, reinforcing its commitment to long-term development in Europe [7] - The establishment of the headquarters signifies deep integration with the local automotive industry [7] Group 8 - New China Life Insurance was approved to participate in the third batch of long-term investment reform trials, aiming to enhance capital market development [8] - The company plans to establish the third phase of the Honghu Fund to facilitate long-term investments [8] Group 9 - Jianbei Miao Miao expects a significant increase of at least 50% in its annual net profit attributable to shareholders for the fiscal year ending March 31, 2025 [9] Group 10 - Leap Motor reported a revenue of 10.02 billion yuan for Q1 2025, representing a year-on-year growth of 187.1% [10] - The growth was driven by a 162.1% increase in sales volume and a 4.9% increase in revenue per vehicle [10] Group 11 - Alibaba Health reported a 13.2% increase in revenue to 30.598 billion yuan for the fiscal year ending March 31, 2025, with adjusted net profit rising by 35.6% [11] - The company achieved a profit attributable to shareholders of 1.432 billion yuan, marking a 62.14% increase [11] Group 12 - Alibaba Pictures reported a 33% increase in revenue to 6.702 billion yuan for the fiscal year ending March 31, 2025, with a net profit attributable to shareholders of 364 million yuan [12] Group 13 - Trip.com Group reported a net operating revenue of 13.8 billion yuan for Q1 2025, reflecting a 16% year-on-year increase [13] - The net profit attributable to shareholders remained stable at 4.3 billion yuan compared to the previous year [13] Group 14 - CSPC Pharmaceutical received FDA fast track designation for its CPO301 drug, aimed at treating advanced non-small cell lung cancer [14] - The drug has also been approved for clinical trials in China [14]

（来源：金石杂谈） 转自：金石杂谈 5月19日，长城基金公募研总廖瀚博火了，一起看看他的投资成绩单。 长城基金廖瀚博，硕士研究生，2012年7月至2014年6月曾就职于长城证券，20114年7月至2015年10月曾就职于海通证券，2015年10月至2017年6月曾就职 于深圳鼎诺投资，这家因经营异常在2023年年初被协会注销。 2017年6月，他正式进军公募，成为长城基金一位研究员，此后做了基金经理助理，到了2018年3月正式成为基金经理。目前他的投资经验已有7年，也成 功升职为公司研究部总经理。 截至目前，廖总管理5只基金，但业绩确实喜忧参半，更确切的说业绩并不好，两款业绩最优异的产品，一只盈利90%，一只盈利75%，但均是2018年和 2019年的产品，而且盈利90%这只你看它的C产品成立三年亏了36%；而近4年来看，他除了2023年12月接管的一只基金盈利近15%，其他三款产品全部录 得约30%的任职亏损。 | 100 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 基金代码 | 基金名称 | 相关链接 | 基金类型 ...

深港通（南向）十大活跃成交公司 | 公司名称 | 成交金额 | 净买入额 | | --- | --- | --- | | 阿里巴巴-W(09988) | 43.40 亿元 | -9.89 亿元 | | 小米集团-W(01810) | 33.93 亿元 | -6092.60 万元 | | 腾讯控股(00700) | 20.48 亿元 | +1.48 亿元 | | 美团-W(03690) | 9.80 亿元 | -1.48 亿元 | | 盈富基金(02800) | 8.04 亿元 | +7.97 亿元 | | 中芯国际(00981) | 7.94 亿元 | +1.61 亿元 | | 泡泡玛特(09992) | 7.06 亿元 | +2.89 亿元 | | 三生制药(01530) | 6.92 亿元 | +1.05 亿元 | | 中国海洋石油(00883) | 4.15 亿元 | -6902.30 万元 | | 华虹半导体(01347) | 4.05 亿元 | +1.38 亿元 | 智通财经APP获悉，2025年5月19日当天，阿里巴巴-W(09988)、小米集团-W(01810)、腾讯控股(00700) 位居沪港 ...

Group 1 - Southbound funds had a significant net purchase of 8.459 billion yuan today [1] - In the Hong Kong Stock Connect (Shanghai), Alibaba-W and China Construction Bank received net purchases of 1.437 billion HKD and 0.862 billion HKD respectively [1] - Tencent Holdings had the highest net sell amount at 0.62 billion HKD [1] Group 2 - In the Hong Kong Stock Connect (Shenzhen), the Yingfu Fund and Pop Mart received net purchases of 0.797 billion HKD and 0.289 billion HKD respectively [1] - Alibaba-W had the highest net sell amount in this segment, totaling 0.989 billion HKD [1]

Group 1: Hong Kong Stock Market Highlights - Midea Group opened up 2% against the market trend after being included in the Hang Seng Index [1] - Yuan Da Pharmaceutical opened over 3% higher, with its first "zero radiation" nuclear medicine factory set to commence production in June [1] - Bruker surged over 6% after being added to the Hang Seng Composite Index, with institutions stating it meets the criteria for inclusion in the Hong Kong Stock Connect [1] - Xuanwu Cloud rose over 22% following a strategic partnership with Tencent Cloud, focusing on AI-driven retail and cloud communication growth [1] - Mixue gained over 5% after being included in the Hang Seng Composite Index, with expectations of being added to the Hong Kong Stock Connect next month [1] - Konnate Optical increased nearly 3% as it plans to invest $4 million in establishing a resin lens production line in Japan [1] - Solar stocks declined, with Q1 solar product exports dropping over 30%, indicating potential pressure on the industry chain [1] - Weilang Delicious rose over 5% after completing a placement that raised over HKD 1.1 billion, with CICC noting the scale of the placement is relatively controllable [1] - Logistics stocks continued to rise, with notable increases in shares of Guangdong-Hong Kong-Macau Holdings, Guangdong Transportation, Kerry Logistics, and ZTO Express [1] Group 2: US Stock Market Highlights - Pony.ai surged nearly 14%, with expectations of achieving positive gross margins for complete vehicles this year [2] - Walmart increased nearly 2% as the company plans to raise prices on certain products in the US [2] - QUBT rose over 39% after turning profitable in Q1 [2] - CoreWeave jumped over 22%, with NVIDIA holding a 7% stake [2] - Bilibili increased over 2%, with Goldman Sachs projecting a 71% year-on-year growth in gaming revenue for Q1 [2] - Hesai Technologies rose over 6% at one point, closing nearly 2% higher amid rumors of a secret application for a Hong Kong listing [2] - Novo Nordisk fell nearly 3% following the announcement of the CEO's departure [2] - Applied Materials (AMAT) dropped over 5% as Q2 revenue fell short of expectations, with a bleak outlook for Q3 [2]

点击小程序查看报告原文 2025年5月16日盘后，恒生指数公司公布了其定期的一季度指数调整结果（此次审议考察截至2025年3月31日，一般在 考察日期后的8周内公布）。此次调整范围涵盖港股主要旗舰指数如恒生、国企指数和恒生科技指数；此外直接决定港 股通可投资范围的恒生综合指数也有局部调整。我们综合分析影响供投资者参考。 指数调整及影响：美的集团与中通快递-W纳入恒指，比亚迪股份纳入恒生科技 ► 成分股变化：美的集团与中通快递-W纳入恒生指数；比亚迪股份纳入恒生科技，阅文集团被剔除。 1) 恒生指数： 此次调整纳入美的集团与中通快递-W，纳入权重分别为0.33%与0.44%，调整后成分股数量增至85只。 2) 恒 生国 企： 此次无纳入剔除，成分股数量维持50只不变。 3) 恒生科 技 ： 此次调整纳入比亚迪股份，纳入权重为8%；阅文集团被剔除，剔除前权重为0.49%。成分股维持在30 只不变。 ► 被动资金流向测算：关注对网易-S、比亚迪股份与中通快递-W等的正面影响；对阅文集团与万洲国际的负面影响。 基于Bloomberg汇总，追踪恒生指数的ETF资金规模约为290.5亿美元，追踪国企和恒生科技指数ETF规 ...